Here are five takeaways:
1. ReWalk Robotics offers external robotic skeletons for those suffering from spinal cord injuries. The company has a robotic device for both home and clinical rehabilitation use.
2. The offering is for about $6.9 million ordinary shares at $1.05 per share.
3. The gross proceedings equal about $7.2 million.
4. National Securities Corporation is the sole underwriter.
5. The offering will likely close Nov. 21.
More articles on devices:
Zimmer Biomet, K2M, Medicrea & more: 6 device company notes
Invibio invests resources to lower healthcare costs: 5 things to know
Medtronic CEO Omar Ishrak: 5 key points on the future of value-based care for device companies
